NEW PepMix Peptide Pools for the highly mutated SARS2 variant Pirola (BA.2.86)!

In late summer, the WHO announced the emergence and spread of the highly mutated SARS-CoV-2 variant BA.2.86 (also known as the Pirola variant), which exhibits over 30 mutations in the spike glycoprotein and has been classified as a variant of concern. We provide researchers with up-to-date PepMix Peptide Pools for immune monitoring and immune response profiling that cover the SARS-CoV-2 virus’ spike glycoprotein and respective RBD: 

• PepMix SARS-CoV-2 (Spike BA.2.86) 
  
• PepMix SARS-CoV-2 (S-RBD BA.2.86) 
  

Our most widely used SARS-CoV-2 peptide pool covers the spike glycoprotein of the Wuhan strain and serves as the native standard when studying the virus’ immune response. Additional information on SARS2 including wild-type and variants, can be found on our website and our references . 

Speaking of endemic infections, please explore our continuously updated portfolio of PepMix Peptide Pools covering common Influenza antigens. We are dedicated to keeping you equipped during new developments. 

If you have any questions, or a tailored Custom Peptide Synthesis request please reach out to our experienced customer support team, here to provide expert guidance.